Novo Nordisk backs out of a diabetes deal with Zosano

Damian Garde

has terminated a collaboration with Pharma, walking away from an agreement that would have paired its late-stage drug with the latter company's microneedle patch technology.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS